Pityriasis Rosea and Pityriasis Rosea-like Eruption Following COVID-19 Vaccinations: Case Series from Oman

Abstract

To mitigate the impact of the COVID-19 pandemic, several vaccines have been developed and administered to the public since 2021. A spectrum of cutaneous reactions has been reported among some of the vaccinated individuals. In this case series, we describe three cases of pityriasis rosea and pityriasis rosea-like eruption that manifested after COVID-19 vaccinations, which might suggest the vaccines as a possible trigger.

Keywords

• covid-19 vaccine pfizer-biontech
• mrna vaccines
• oxford-astrazeneca covid-19 vaccine
• pityriasis rosea
• pityriasis rosea-like eruption
• oman